Use of aldose reductase inhibitors to enhance insulin...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/224, 167/227

A61K 31/33 (2006.01) A61K 31/195 (2006.01) A61K 31/40 (2006.01) A61K 31/415 (2006.01) A61K 31/42 (2006.01) A61K 31/44 (2006.01) A61K 31/50 (2006.01)

Patent

CA 1310269

Abstract A method of enhancing insulin sensitivity in mammals (e.g., humans) is described. The method is based on the use of aldose reductase inhibitors to restore and preserve intracellular reduced glutathione levels, thereby enhancing the formation of insulin receptor-mixed disulfide bonds.

561908

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of aldose reductase inhibitors to enhance insulin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of aldose reductase inhibitors to enhance insulin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of aldose reductase inhibitors to enhance insulin... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1200720

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.